Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 34 minutes ago
Back to Filings
FORM 144
AI

144 - December 3, 2024

Filed December 3, 2024
·
0002001011-24-000094

Rocket Lab officer Slusky files Form 144 to sell 100,000 shares worth $2.3M.

Brief

This Form 144 discloses Alexander R. Slusky, an officer of Rocket Lab USA, Inc., proposing to sell 100,000 shares of common stock valued at $2,301,000 on or around December 6, 2024. The shares, held by Abalone Cove LLLP under his dispositive control, were acquired via the 2021 De-SPAC transaction. No sales reported in the past 3 months; relevant for investors tracking insider activity.

Detailed Brief

Form 144 is a notice of proposed sale of restricted securities under Rule 144 by affiliates. Here, Alexander R. Slusky, listed as an Officer, intends to sell 100,000 common shares through Charles Schwab & Co., with an aggregate market value of $2,301,000 based on current prices (implying ~$23.01/share), out of 504,221,698 shares outstanding. The shares originate from private financings by Vector Capital V, L.P., converted during Rocket Lab's August 25, 2021 De-SPAC merger (634,675 shares acquired). Slusky holds dispositive power over shares in Abalone Cove LLLP. No sales by him in the prior 3 months, and he certifies no undisclosed material adverse information. This routine pre-sale notice provides transparency on insider liquidity events amid Rocket Lab's growth in launch services and space systems.

Key Telemetry

  • Alexander R. Slusky (Officer) to sell 100,000 common shares (~$2.301M value) on ~12/06/2024.
  • Shares held by Abalone Cove LLLP (Slusky dispositive control), acquired 08/25/2021 via De-SPAC (634,675 total).
  • No insider sales in past 3 months reported.
  • Broker: Charles Schwab; NASDAQ-listed.
  • Certifies no undisclosed material adverse info.

Impact Vector

For Rocket Lab investors, this planned insider sale by Officer Slusky signals potential personal liquidity needs rather than bearish views, given the certification of no adverse info and Rule 144 compliance. Non-dilutive as existing shares; minor relative to 504M outstanding (0.02%). Monitor for sale execution, volume, and any cluster of insider activity amid RKLB's Neutron development and Neutron. Strategic irrelevance but routine transparency.

Search
Search across missions, customers, news, and SEC filings